Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$0.21 - $0.31 $2,570 - $3,794
-12,239 Reduced 21.18%
45,546 $10,000
Q4 2022

Feb 14, 2023

SELL
$0.18 - $0.28 $23,233 - $36,141
-129,076 Reduced 69.08%
57,785 $13,000
Q3 2022

Nov 14, 2022

BUY
$0.28 - $0.72 $47,575 - $122,338
169,914 Added 1002.62%
186,861 $55,000

About AGILE THERAPEUTICS INC


  • Ticker AGRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 39,023,000
  • Market Cap $55.4M
  • Description
  • Agile Therapeutics, Inc., a women's healthcare company, researches, develops, and commercializes prescription contraceptive products for women in the United States. Its lead product is Twirla, also known as AG200-15, a once-weekly prescription combination hormonal contraceptive patch. The company is also developing a pipeline of Twirla line exte...
More about AGRX
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.